Diligence memo · auto-generated · as of July 2, 2026
MetaBiotech Corp
MetaBiotech Corp looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
MetaBiotech Corp operates in Biotechnology, based in SAN JOSE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MetaBiotech Corp has raised $9.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $9.2M on 2018-01-30.
Most recent recorded round closed around 2018-01-30.
Valuation (modeled)modeled
Provath models MetaBiotech Corp at approximately $332M (range $10M–$1.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.57× the median modeled value of Series A Biotechnology companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 8.4 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 54% of Biotechnology peers (4293 compared).
Modeled value ranks above 78% of those peers.
Closest niche peers: Bio-Dent, LTD. LLC, Anthera Pharmaceuticals Inc, Cynvec LLC, Biothera Holding Corp., Limelight Bio, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.